More than 150 Lek and Novartis associates in Slovenia engage in voluntary activities in their communities
- Novartis organizes annual Community Partnership Day to commemorate the company’s creation in 1996
- The objective of the initiative is to support projects in the local communities, social institutions and non-profit organizations which correspond to Novartis’ commitment to Corporate Citizenship
- Novartis event emphasizes strong commitment to Corporate Citizenship
Today, Lek associates participated in Community Partnership Day for the third year in a row. On this day, associates who choose to participate take time off from work in order to take part in volunteer activities to benefit people and various organizations in their local communities. When Lek first joined the Novartis event and held Community Partnership Day it was immediately apparent that for many people the time and effort donated by the volunteers were as valuable as financial assistance.
This year marks Novartis’ 12th Community Partnership Day, and in this time the initiative has become an important part of the company’s Corporate Citizenship. At Lek as well, Community Partnership Day has become one of the most important Corporate Citizenship activities, as it encourages associates to engage in volunteer work. The associates donate their time and effort in order to brighten up other people’s days, and this in turn helps both the recipients of the assistance and the volunteers themselves.
This year the Lek associates together with their colleagues from Novartis Pharma Slovenia took part in ten separate activities, which involved more than 150 volunteers. In Ljubljana they cooked warm meals for the homeless and served them at the Parish Caritas in Štepanja vas, at the homeless shelter on Poljanska street and at the Franciscan church. The children at the Soča Rehabilitation Institute were entertained by Grega the Magician, who enthralled them with magic tricks and singing. They visited the Thumbelina Safe House in Grosuplje, where they painted the wooden exterior of the house and planted flowers, and the Rakitna Climatic Spa for Children, where they landscaped part of the grounds and planted greenery. Every year, associates at every location in Slovenia (Ljubljana, Mengeš, Lendava and Prevalje) also donated blood. A day of fun social events was held at the elderly people’s homes in Mengeš and Medvode. Social activities were also held for the inhabitants at the Tončka Hočevar Work and Safety Center, using items which the Lek associates had collected that they can use every day, such as games, sewing equipment and material, and arts and crafts materials such as paint, modeling clay, decorative paper etc. One group of Lek associates took cihldren from the Fužine Day Care Center on a trip to the zoo. Landscaping and cleanup work was done for an associate in Koroška whose house burned down last year. And Lek associates from Ljubljana and Lendava assisted at the 15th Special Olympics for the Maribor-Pomurje region.
Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for active pharmaceutical ingredients and medicines, as a competence center for the development of vertically integrated products, as a Sandoz competence center in the field of development and manufacturing of biosimilars and as a supply center for the markets of CEE, SEE and CIS, sales Slovenia and sales services for Sandoz global markets. Lek d.d. employs more than 3,000 people. For further information please consult http://www.lek.si.
Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of more than 950 compounds and sells its products in more than 130 countries. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany) and EonLabs (US) In 2007, Sandoz employed around 23,000 people worldwide and posted sales of USD 7.2 billion.
Novartis AG provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on growth areas in healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group’s continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout
the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 98,200 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For further information contact:
Katarina Klemenc Dinjaški
Lek Pharmaceuticals d.d.
Phone: + 386 1 580 22 43
Fax: + 386 1 580 24 32